One mechanism that springs to mind here is the accumulation of transthyretin amyloid, found in one small study to be the majority cause of death in supercentenarians, but which appears to have only a smaller impact on mortality in younger old age - it is implicated in something like 10% of heart failure cases, for example. Can we argue that advances in medicine and public health over the past century have had little to no impact on the accumulation of misfolded transthyretin deposits in tissues, and thus this mechanism acts as a limit on life span? Or do some of these improvements in fact produce an small, incidental reduction in amyloid burden in later life? The evidence to support any of the possible positions on these questions is presently lacking.
Whatever the state of effective limits on life span today, however, the limits on life span tomorrow are determined by progress towards rejuvenation therapies. There are treatments under development that can clear transthyretin amyloid from tissues, for example, such as the work of Pentraxin Therapeutics, or the catalytic antibody development funded by the SENS Research Foundation.
But there's no evidence that will happen. I can imagine being headed towards 150-year lifespans, there's just no evidence we're on that track right now.
[1] https://sciencealert.com/turns-out-crispr-gene-editing-can-c...
> There currently is an upper limit, and the upper limit is probably around 115, 120. You have a very large number—100 billion people to choose the number of people that have ever lived—and you have only one who has made it through to 122, Jeanne Calment. The second oldest was 119. It does seem there is an upper limit. Some people have shown that in the last hundred years, even though we have progressively increased the average lifespan, the number of people who live above 115 has not increased.
I also couldn't help but think that his remarks about immortality being the naughty "I-word" is a roundabout way of addressing some of the excitement stirred by a certain slightly sensationalistic wizardly chap in the aging field.